Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Committee advances bill to reduce barriers and speed access to hepatitis C treatment
Summary
AB 1843 would remove administrative barriers to timely, curative hepatitis C treatment; the author told the committee the disease is curable in over 95% of cases but still causes nearly 1,500 deaths annually in California, and proponents cited minimal premium impacts in CHBURP analysis.
Assemblymember Elwhare presented AB 1843 to the Appropriations Committee on May 6, describing the measure as an effort to remove unnecessary administrative hurdles and speed patient access to curative hepatitis C treatment.
"Hepatitis C is curable in over 95 percent of cases," the author said, and delayed treatment contributes to about 1,500 deaths annually in California. Elwhare…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
